Impact of lowering triglycerides on raising HDL-C in hypertriglyceridemic and non-hypertriglyceridemic subjects

Area of Science:

• Cardiology
• Lipid Metabolism
• Preventive Medicine

Background:

• An inverse association between triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) is established.
• The effect of TG-lowering interventions on HDL-C levels requires further elucidation.

Purpose of the Study:

• To investigate the independent impact of reducing triglyceride levels on high-density lipoprotein cholesterol in dyslipidemic patients.
• To determine if the TG-lowering effect on HDL-C differs based on baseline TG levels.

Main Methods:

• Analysis of data from 151 dyslipidemic patients with 1830 visits between 1991 and 2005.
• Mixed regression modeling to assess the association between TG reduction and HDL-C changes, adjusting for various therapies.
• Categorization of patients based on baseline TG levels (median: 178 mg/dL; hypertriglyceridemia: ≥200 mg/dL).

Main Results:

• Baseline TG levels ≥178 mg/dL were associated with significantly lower HDL-C compared to levels below the median.
• Each 50 mg/dL TG reduction correlated with a 0.5 mg/dL HDL-C increase in hypertriglyceridemic subjects and a 1.7 mg/dL increase in those without elevated TG.
• Niacin, statins, and fibrates independently increased HDL-C beyond TG reduction effects.

Conclusions:

• Lowering triglyceride levels is independently and inversely correlated with HDL-C levels.
• The positive impact of TG reduction on HDL-C is more pronounced in individuals without hypertriglyceridemia.
• Pharmacological interventions like niacin, statins, and fibrates contribute to HDL-C elevation beyond their TG-lowering effects.